Alternative to intensive management of the active phase of the second stage of labor: a multicenter randomized trial (Phase Active du Second STade trial) among nulliparous women with an epidural.

Am J Obstet Gynecol

Obstetrical Perinatal and Pediatric Epidemiology Research Team, Centre of Research in Epidemiology and Statistics Sorbonne Paris Cité, National Institute of Health and Medical Research, French National Institute for Agricultural Research, University of Paris, Paris, France.

Published: October 2022

AI Article Synopsis

  • The study examined the effects of "moderate" vs "intensive" pushing during the second stage of labor on neonatal health outcomes.
  • The research involved 1710 first-time mothers and compared outcomes between two groups: one with moderated pushing and another with intensive pushing, assessing factors like neonatal morbidity and mode of delivery.
  • Results showed that while the neonatal morbidity was slightly lower in the moderate group (18.9%) compared to the intensive group (20.6%), those in the moderate group pushed longer, averaging 38.8 minutes compared to 28.6 minutes for the intensive group.

Article Abstract

Background: There is no consensus on an optimal strategy for managing the active phase of the second stage of labor. Intensive pushing could not only reduce pushing duration, but also increase abnormal fetal heart rate because of cord compression and reduced placental perfusion and oxygenation resulting from the combination of uterine contractions and maternal expulsive forces. Therefore, it may increase the risk of neonatal acidosis and the need for operative vaginal delivery.

Objective: This study aimed to assess the effect of the management encouraging "moderate" pushing vs "intensive" pushing on neonatal morbidity.

Study Design: This study was a multicenter randomized controlled trial, including nulliparas in the second stage of labor with an epidural and a singleton cephalic fetus at term and with a normal fetal heart rate. Of note, 2 groups were defined: (1) the moderate pushing group, in which women had no time limit on pushing, pushed only twice during each contraction, and observed regular periods without pushing, and (2) the intensive pushing group, in which women pushed 3 times during each contraction and the midwife called an obstetrician after 30 minutes of pushing to discuss operative delivery (standard care). The primary outcome was a composite neonatal morbidity criterion, including umbilical arterial pH of <7.15, base excess of >10 mmol/L, lactate levels of >6 mmol/L, 5-minute Apgar score of <7, and severe neonatal trauma. The secondary outcomes were mode of delivery, episiotomy, obstetrical anal sphincter injuries, postpartum hemorrhage, and maternal satisfaction.

Results: The study included 1710 nulliparous women. The neonatal morbidity rate was 18.9% in the moderate pushing group and 20.6% in the intensive pushing group (P=.38). Pushing duration was longer in the moderate group than in the intensive group (38.8±26.4 vs 28.6±17.0 minutes; P<.001), and its rate of operative delivery was 21.1% in the moderate group compared with 24.8% in the intensive group (P=.08). The episiotomy rate was significantly lower in the moderate pushing group than in the intensive pushing group (13.5% vs 17.8%; P=.02). We found no significant difference for obstetrical anal sphincter injuries, postpartum hemorrhage, or maternal satisfaction.

Conclusion: Moderate pushing has no effect on neonatal morbidity, but it may nonetheless have benefits, as it was associated with a lower episiotomy rate.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2022.07.025DOI Listing

Publication Analysis

Top Keywords

second stage
12
stage labor
12
pushing
9
active phase
8
phase second
8
multicenter randomized
8
intensive pushing
8
fetal heart
8
heart rate
8
pushing group
8

Similar Publications

Objective: For full expansion of ear reconstruction, the stability of a cartilage framework is very important. However, most techniques for framework fabrication focus on three-dimensional structure and adequate projection. Few studies are available on improving the stability of the reconstructed framework.

View Article and Find Full Text PDF

Highly energetic boron (B) particles embedded in hydroxyl-terminated polybutadiene (HTPB) thermosetting polymers represent stable solid-state fuel. Laser-heating of levitated B/HTPB and pure HTPB particles in a controlled atmosphere revealed spontaneous ignition of B/HTPB in air, allowing for examination of the exclusive roles of boron. These ignition events are probed via simultaneous spectroscopic diagnostics: Raman and infrared spectroscopy, temporally resolved high-speed optical and infrared cameras, and ultraviolet-visible (UV-vis) spectroscopy.

View Article and Find Full Text PDF

Background And Objectives: Blood-based biomarkers of amyloid and tau have been shown to predict Alzheimer disease (AD) dementia. Much less is known about their ability to predict risk of mild cognitive impairment (MCI), an earlier disease stage. This study examined whether levels of blood biomarkers of amyloid (Aβ/Aβ ratio), tau (p-tau), neurodegeneration (NfL), and glial activation and neuroinflammation (glial fibrillary acidic protein [GFAP], YKL40, soluble triggering receptor expressed on myeloid cells 2 [sTREM2]) collected when participants were cognitively normal are associated with the time to onset of MCI.

View Article and Find Full Text PDF

Computational Analysis of MDR1 Variants Predicts Effect on Cancer Cells via their Effect on mRNA Folding.

PLoS Comput Biol

December 2024

Department of Biomedical Engineering, the Engineering Faculty, Tel Aviv University, Tel-Aviv, Israel.

The P-glycoprotein efflux pump, encoded by the MDR1 gene, is an ATP-driven transporter capable of expelling a diverse array of compounds from cells. Overexpression of this protein is implicated in the multi-drug resistant phenotype observed in various cancers. Numerous studies have attempted to decipher the impact of genetic variants within MDR1 on P-glycoprotein expression, functional activity, and clinical outcomes in cancer patients.

View Article and Find Full Text PDF

Autophagy is a key biological process that has proven extremely difficult to detect noninvasively. To address this, an autophagy detecting nanoparticle (ADN) was recently developed, consisting of an iron oxide nanoparticle decorated with cathepsin-cleavable arginine-rich peptides bound to the near-infrared fluorochrome Cy5.5.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!